Sunpharma

3,997 views

Published on

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
3,997
On SlideShare
0
From Embeds
0
Number of Embeds
8
Actions
Shares
0
Downloads
171
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Sunpharma

  1. 1.
  2. 2. ABOUT COMPANY<br /><ul><li>Chronic Therapy
  3. 3. Startup with just 5 products in 1983
  4. 4. Sales were initially limited to 2 states West Bengal and Bihar.
  5. 5. leading pharmacy company in India.
  6. 6. Sun Pharma owns approx 76% on a diluted basis of the outstanding common shares of Caraco.
  7. 7. Headquarter in Mumbai.
  8. 8. Sun Pharma has two R&D centers in Baroda and Mumbai.</li></li></ul><li><ul><li>Sun Pharma was listed on the main stock exchanges in India in 1994.
  9. 9. It currently markets 58 products and had reported a turnover of Rs.222 mill with a profit of Rs.49 mill for the year ending March 09.
  10. 10. The Rs 55 crore issue of a Rs. 10 face value equity share at a premium of Rs. 140/- was oversubscribed 55 times.
  11. 11. 8000 employees.
  12. 12. 2 World class research centers.
  13. 13. 60% of sales from international markets.</li></li></ul><li>PROFITABILITY SUSTAINABLE<br />
  14. 14. FINANCIAL HIGHLIGHTS<br />
  15. 15.
  16. 16.
  17. 17. Your Directors take pleasure in presenting the Seventeenth Annual Report and Audited<br />Accounts for the year ended 31st March, 2009.<br />(Rs. in million except book value and dividend per share)<br />
  18. 18. Your Directors are pleased to recommend an equity dividend of Rs.13.75 per equity share of face value Rs.5/- each (previous year Rs.10.50 per equity share of face value Rs.5/- each)for the year ended 31st March, 2009.<br />DIVIDEND<br />
  19. 19. BONUS SHARES<br /><ul><li> 161,630,010 Equity shares were allotted as fully paid Bonus Shares by capitalization of Securities Premium Account, Profit and Loss Account, Amalgamation Reserve and Capital Redemption Reserve Account, without payment being received in cash.
  20. 20. 187,177,232 6% Cumulative Redeemable Preference Shares of Re.1 each allotted as fully paid bonus shares, to the equity share holders, by capitalization of Capital Redemption reserve. </li></li></ul><li>
  21. 21.
  22. 22.
  23. 23. CASH FLOW STATEMENT FOR THE YEAR ENDED 31st MARCH 2009<br />

×